
TransMedics Group (TMDX) Financial Success Faces Legal Scrutiny Amid Allegations – Hagens Berman
SAN FRANCISCO, April 06, 2025 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (NASDAQ: TMDX) reported blockbuster Q4 2024 earnings in late February 2025, booking $121.6 million in revenue (up 50% year-over-year) and $35.5 million in full-year net income, …